Loading
Latest filing published 06 Apr 2026 for 엔지켐생명과학, €4.9M. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
윤영배 (chief executive) discloses dealings in 엔지켐생명과학 to DART (FSS). The record holds 55 filings, for trades running from 30 September 2021 to 31 March 2026.
Every open-market trade on record is a purchase: 54 purchases worth €4.9M, and no sale. The totals exclude 53 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2026 alone, the filings show 1 purchase and no sales.
No cluster: in 53 purchases, no other insider of the company bought within 30 days.
On 6 April 2026 came the latest disclosure, an open-market purchase for €4.9M in 엔지켐생명과학. The median gap between a trade and its publication by DART (FSS) is 7 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 55 declarations